EDGAR Filing Documents for 0001193125-20-053023

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001193125-20-053023

Filing Date

2020-02-27

Accepted

2020-02-27 17:26:22

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	d896669d424b5.htm	424B5	330387
2	GRAPHIC	g896669g26c50.jpg	GRAPHIC	82178
3	GRAPHIC	g896669g42y71.jpg	GRAPHIC	128770
4	GRAPHIC	g896669g52e35.jpg	GRAPHIC	38119
5	GRAPHIC	g896669g78c42.jpg	GRAPHIC	39637
6	GRAPHIC	g896669g99g96.jpg	GRAPHIC	138633
	Complete submission text file	0001193125-20-053023.txt		900992

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-228203 | Film No.: 20663929
SIC: 2834 Pharmaceutical Preparations